| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/22/2000 | EP0986527A1 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst |
| 03/22/2000 | EP0986384A1 Inhibitors of protein isoprenyl transferases |
| 03/22/2000 | EP0889918B1 In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 03/22/2000 | EP0620814B1 Novel piprazine carboxamides |
| 03/22/2000 | CN1248250A Novel 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes |
| 03/22/2000 | CN1247863A Carriers for combination of organic synthetic connecting material, their prepn. and use |
| 03/22/2000 | CN1050514C Antiallergic composition for ophthalmic or nasal use |
| 03/21/2000 | US6040448 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands |
| 03/21/2000 | US6040422 Reacting a fluoroformamidinium salt with an n-amino protected, optionally side chain protected amino acid; then reacting product with a carboxy protected amino acid; for compounds with long term storage stability |
| 03/21/2000 | US6040339 Treatment and prophylaxis of hypercholesteremia or arteriosclerosis in a mammal |
| 03/21/2000 | US6040302 1,4-disubstituted piperazines |
| 03/16/2000 | WO2000014065A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | WO2000014063A1 Therapeutic compounds and methods |
| 03/16/2000 | WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders |
| 03/16/2000 | CA2342994A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 03/16/2000 | CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv |
| 03/15/2000 | EP0985662A2 Linker binding carriers for organic synthesis, their production and use |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984909A1 Use of a rhodium catalyst for hydroamination and/or oxidative amination of aryl-substituted olefins and method for producing a 2-aryl vinyl amine |
| 03/15/2000 | EP0984778A1 Neuropeptide-y ligands |
| 03/15/2000 | EP0984777A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
| 03/15/2000 | CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them |
| 03/14/2000 | USRE36617 (Substituted aralkyl) heterocyclic compounds |
| 03/14/2000 | US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis |
| 03/14/2000 | US6037352 N-substituted piperidine derivatives; treating alzheimer*s disease, nervous system disorders; acetylcholinesterase inhibitors |
| 03/14/2000 | US6037157 Method for improving pharmacokinetics |
| 03/10/2000 | CA2281490A1 Linker-bound carriers for organic synthesis, their production and use |
| 03/09/2000 | WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 03/09/2000 | WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 03/09/2000 | WO2000012454A1 Novel polycationic lipids |
| 03/09/2000 | WO2000012083A1 Formamides as therapeutic agents |
| 03/09/2000 | WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/09/2000 | WO2000012073A1 Use of 5ht-6 antagonists |
| 03/09/2000 | WO1999062893A3 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 03/09/2000 | CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/08/2000 | EP0983996A1 Cationic ortho-phenylenediamines, their use for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 03/08/2000 | EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 03/08/2000 | EP0983228A1 Protease inhibitors |
| 03/08/2000 | EP0983222A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 03/08/2000 | EP0944609A4 Process for preparing n-alkyl ammonium acetonitrile compounds |
| 03/08/2000 | CN1050122C Benzimidazoles, pharmaceutical compositions containing these compounds and process for preparing them |
| 03/07/2000 | US6034240 Substituted aminomethylphosphines, coordination complexes of aminomethylphosphines and their synthesis |
| 03/07/2000 | US6034216 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/07/2000 | US6034136 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 03/07/2000 | US6034134 1-Amino-alkylcyclohexane NMDA receptor antagonists |
| 03/07/2000 | US6034127 Amidino protease inhibitors |
| 03/07/2000 | US6034102 Atherosclerosis treatment |
| 03/07/2000 | US6034095 Rheumatic diseases; osteoporosis |
| 03/07/2000 | US6034086 Viricides; aids therapy |
| 03/07/2000 | CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these |
| 03/02/2000 | WO2000011041A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent |
| 03/02/2000 | WO2000010970A1 Methoximinophenylacetic acid amides |
| 03/02/2000 | WO2000010964A1 Photoactivatable bases containing nitrogen |
| 03/02/2000 | WO2000010544A2 A method for preventing the onset of asthma |
| 03/02/2000 | CA2337428A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent |
| 03/02/2000 | CA2280989A1 New cationic orthophenylenediamines, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing processes |
| 03/01/2000 | EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| 03/01/2000 | EP0982293A1 Process for the preparation of imines and enamines, and possibly their further hydrogenation into amines |
| 03/01/2000 | EP0981527A1 Salt of naphthyridine carboxylic acid derivative |
| 03/01/2000 | CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments |
| 03/01/2000 | CN1246110A Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 03/01/2000 | CN1246109A 5-aroylnaphthalene derivatives |
| 03/01/2000 | CN1049888C Process for preparing benzoylguanidine |
| 02/29/2000 | US6031131 Fluorinated amide compounds |
| 02/29/2000 | US6031130 Catalyzing the dehydration of a secondary amine compound by adding a rhenium catalyst and aqueous hydrogen peroxide to a mixture also containing a dehydrating agent; use as photographic developers, additives for polymers |
| 02/29/2000 | US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse; |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/24/2000 | WO2000009471A1 Divinylstilbenesulfonic acid derivatives |
| 02/24/2000 | WO2000009116A1 Grp receptor ligands |
| 02/24/2000 | WO2000009115A1 Grp receptor ligands |
| 02/24/2000 | WO1999055687A3 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases |
| 02/24/2000 | DE19925780A1 New 2-methoxyimino-2-phenyl-acetamide derivatives useful as microbicides, especially fungicides for plant protection |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | CN1245495A N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 02/23/2000 | CN1245494A New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245162A Process for preparing amine |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028195 Piperazine derivatives and process for the preparation thereof |
| 02/22/2000 | US6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
| 02/22/2000 | US6028063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
| 02/22/2000 | CA2050352C Substituted 2-propenyl derivatives of nitrogen heterocycles |
| 02/17/2000 | WO2000008032A1 Catalyst ligands useful for cross-coupling reactions |
| 02/17/2000 | WO2000008018A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 02/17/2000 | WO2000008006A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO1999054310A3 New substituted amides, their production and their use |
| 02/17/2000 | DE19836814A1 Verfahren zur Herstellung von Iminen und Enaminen und gegebenenfalls deren Weiterhydrierung zu Aminen Process for the preparation of imines and enamines and optionally the further hydrogenation to amines |
| 02/17/2000 | CA2339662A1 Benzothiepin derivatives, their production and use |
| 02/17/2000 | CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | CA2305406A1 Pharmaceutical compounds |